Sort
130,381 grants matching “hiv”
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERS
$2,491,205Jose Ginel Rodriguez · Universidad Central Del Caribe · G12 · FY2010 · RR
Development of Vaccines to Prevent Tuberculosis
$2,490,549Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Disease Status Drug Metabolism and New Drug Discovery
$2,490,069Irving William Wainer · National Institute On Aging · ZIA · FY2013 · AG
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA
$2,490,000Sumathi Sivapalasingam · New York University School Of Medicine · U62 · FY2009 · PS
Biology of Mammalian Base Excision Repair and HIV-1 Replication
$2,489,765Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
NICHD Bioinformatics and Scientific Programming Core
$2,488,565Ryan Dale · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2022 · HD
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$2,488,424Catherine C McGowan · Vanderbilt University · U01 · FY2013 · AI
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,488,242Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2012 · HL
Vanderbilt HIV Clinical Trials Unit
$2,487,433David W Haas · Vanderbilt University Medical Center · UM1 · FY2020 · AI
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERS
$2,487,409Jose Ginel Rodriguez · Universidad Central Del Caribe · G12 · FY2012 · MD
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
$2,486,704Barbara Driver · Westat, Inc. · N01 · FY2021 · HD
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,486,098Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
MACS/WIHS -CCS
$2,485,217Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2020 · HL
UCLA Center for AIDS Research (CFAR)
$2,485,000Jerome A. Zack · University Of California Los Angeles · P30 · FY2008 · AI
Human anti-viral immune responses in tissues and circulation
$2,484,908Donna L Farber · Columbia University Health Sciences · U19 · FY2017 · AI
Epidemiology and Natural History of Cancer-Associated Viruses
$2,483,980Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
NIDA Clinical Trials Network: Greater New York Node
$2,483,943John P Rotrosen · New York University School Of Medicine · UG1 · FY2017 · DA
Acylovir to prevent HIV acquisition in HSV-2+persons
$2,481,754University Of Washington · R01 · FY2003 · AI
Immune Monitoring
$2,481,595Clive Maurice Gray · Duke University · U19 · FY2010 · AI
Small-Molecule Antibody Recruiting Therapeutics for Treating Human Disease
$2,481,250David Adam Spiegel · Yale University · DP2 · FY2007 · OD
Illinois Department of Public Health Imperative: Reduce HIV-Related Morbidity, Mo
$2,481,140Mildred Williamson · Illinois State Dept Of Public Health · U62 · FY2014 · PS
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,480,863Shruti H Mehta · Johns Hopkins University · U01 · FY2022 · DA
University of Puerto Rico Clinical Trials Unit
$2,480,642Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2009 · AI
UCSF-GIVI Center for AIDS research
$2,480,262University Of California San Francisco · P30 · FY2004 · AI
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,480,144Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI